In Swaziland, the country with the highest HIV prevalence in the world, a consortium of multi-disciplinary stakeholders, led by the Government of Swaziland, is managing MaxART – Maximizing ART for Better Health and Zero New HIV Infections. MaxART is a comprehensive programme that combines innovative activities designed to overcome many of the remaining barriers preventing Swaziland from realizing its potential and to maximize the impact of Swaziland’s current national HIV testing, care, and treatment efforts. This involves strengthening facility and community systems, expanding and decentralizing treatment for all who currently need it, promoting all aspects of care, and ensuring high quality services so that people are retained in care. Further, MaxART includes social science research and mathematical and epidemiological modeling to better understand issues including loss of clients living with HIV but not yet ready for ART from the health system, under-utilization of services among marginalized and vulnerable populations, and the ethical and human rights implications of expanding HIV testing, care, and treatment on such a comprehensive scale.
With these strong systems and improved understanding of the realities and needs on the ground, Swaziland is also embarking on a 3-year Treatment as Prevention Implementation Study to understand the feasibility, acceptability, outcomes, affordability, and scalability of offering treatment for people living with HIV, irrespective of CD4 and viral load, within the national health system. All interventions within MaxART are being implemented and coordinated with the initiatives of other donors and partners, already underway in Swaziland.
Founded in 2002, by President William J. Clinton, the Clinton Health Access Initiative (CHAI) is a global health organization committed to strengthening integrated health systems around the world and expanding access to care and treatment for HIV/AIDS, malaria and other illnesses. Based on the premise that business-oriented strategy can facilitate solutions to global health challenges, CHAI acts as a catalyst to mobilize new resources and optimize the impact of these resources to save lives, via improved market organization, management support, and strategic use of data to inform evidence-based, cost-effective policies and programs. By working in association with governments and other NGO partners, CHAI is focused on large-scale impact.
The MaxART TasP Principal Investigator will be jointly responsible with the Principal Investigator from the Ministry of Health (MOH) for the design, management, and evaluation of this Treatment as Prevention Implementation Study. Specific responsibilities include:
The MaxART TasP Principal Investigator will report to the Clinton Health Access Initiative Country Director in Swaziland and will work closely with the entire MaxART Consortium and Study Team.
Be part of our network of leaders and innovators.Join now